These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8383941)

  • 1. Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium.
    Naidu SS; Svensson U; Kishore AR; Naidu AS
    Antimicrob Agents Chemother; 1993 Feb; 37(2):240-5. PubMed ID: 8383941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactoferrin binds to porins OmpF and OmpC in Escherichia coli.
    Erdei J; Forsgren A; Naidu AS
    Infect Immun; 1994 Apr; 62(4):1236-40. PubMed ID: 8132330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferrin-binding proteins in Shigella flexneri.
    Tigyi Z; Kishore AR; Maeland JA; Forsgren A; Naidu AS
    Infect Immun; 1992 Jul; 60(7):2619-26. PubMed ID: 1319403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin interaction with salmonellae potentiates antibiotic susceptibility in vitro.
    Naidu AS; Arnold RR
    Diagn Microbiol Infect Dis; 1994 Oct; 20(2):69-75. PubMed ID: 7867307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porins and lipopolysaccharide of Escherichia coli ATCC 25922 and isogenic rough mutants.
    Rivera M; Bertasso A; McCaffrey C; Georgopapadakou NH
    FEMS Microbiol Lett; 1993 Apr; 108(2):183-7. PubMed ID: 8387443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between human lactoferrin binding and colicin susceptibility in Escherichia coli.
    Gadó I; Erdei J; Laszlo VG; Pászti J; Czirók E; Kontrohr T; Tóth I; Forsgren A; Naidu AS
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2538-43. PubMed ID: 1810187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porins OmpC and PhoE of Escherichia coli as specific cell-surface targets of human lactoferrin. Binding characteristics and biological effects.
    Sallmann FR; Baveye-Descamps S; Pattus F; Salmon V; Branza N; Spik G; Legrand D
    J Biol Chem; 1999 Jun; 274(23):16107-14. PubMed ID: 10347162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lipopolysaccharide structure on reactivity of antiporin monoclonal antibodies with the bacterial cell surface.
    Bentley AT; Klebba PE
    J Bacteriol; 1988 Mar; 170(3):1063-8. PubMed ID: 2830227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.
    Weiss J; Beckerdite-Quagliata S; Elsbach P
    J Clin Invest; 1980 Mar; 65(3):619-28. PubMed ID: 6986410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity of specific and azurophil granules from human neutrophils: studies with outer-membrane mutants of Salmonella typhimurium LT-2.
    Rest RF; Cooney MH; Spitznagel JK
    Infect Immun; 1978 Jan; 19(1):131-7. PubMed ID: 24000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activities of tosufloxacin against and uptake of tosufloxacin by outer membrane mutants of Escherichia coli, Proteus mirabilis, and Salmonella typhimurium.
    Mitsuyama J; Itoh Y; Takahata M; Okamoto S; Yasuda T
    Antimicrob Agents Chemother; 1992 Sep; 36(9):2030-6. PubMed ID: 1329639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane permeability channels in vesicles reconstituted from single species of porins from Salmonella typhimurium.
    Nakae T; Ishii J
    J Bacteriol; 1978 Mar; 133(3):1412-8. PubMed ID: 346571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Escherichia coli K-12 OmpF trimers with rough and smooth lipopolysaccharides.
    Diedrich DL; Stein MA; Schnaitman CA
    J Bacteriol; 1990 Sep; 172(9):5307-11. PubMed ID: 2168378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule lactoferrin with an inflammatory effect but no apparent antibacterial activity in mastitic mammary gland secretion.
    Komine K; Komine Y; Kuroishi T; Kobayashi J; Obara Y; Kumagai K
    J Vet Med Sci; 2005 Jul; 67(7):667-77. PubMed ID: 16082114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14.
    Caccavo D; Afeltra A; Pece S; Giuliani G; Freudenberg M; Galanos C; Jirillo E
    Infect Immun; 1999 Sep; 67(9):4668-72. PubMed ID: 10456914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.
    Elass-Rochard E; Roseanu A; Legrand D; Trif M; Salmon V; Motas C; Montreuil J; Spik G
    Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):839-45. PubMed ID: 8554529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasticity of Escherichia coli porin channels. Dependence of their conductance on strain and lipid environment.
    Buehler LK; Kusumoto S; Zhang H; Rosenbusch JP
    J Biol Chem; 1991 Dec; 266(36):24446-50. PubMed ID: 1722204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide structure required for in vitro trimerization of Escherichia coli OmpF porin.
    Sen K; Nikaido H
    J Bacteriol; 1991 Jan; 173(2):926-8. PubMed ID: 1702785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of KB-5246 against outer membrane mutants of Escherichia coli and Salmonella typhimurium.
    Kotera Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1323-5. PubMed ID: 2167038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific binding of lactoferrin to Aeromonas hydrophila.
    Kishore AR; Erdei J; Naidu SS; Falsen E; Forsgren A; Naidu AS
    FEMS Microbiol Lett; 1991 Sep; 67(1):115-9. PubMed ID: 1778417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.